republic-os/legislation/us/states/in/2023/hb-1445.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Audit of Medicaid program prescription drug costs.	Amends the requirements for a physician to provide office based opioid treatment. Provides that the attorney general may issue a request for proposal to audit the prescription drug programs within the state employee health plan and the Medicaid program. Provides that the attorney general may evaluate and determine whether to include specified metrics in the request for proposal. Provides that the audit look back period must be the previous five state fiscal years. Provides that the results of the audits must be provided to the interim study committee on public health, behavioral health, and human services before September 1, 2024. Provides that a practitioner is not required to obtain information about a patient from the Indiana scheduled prescription electronic collection and tracking program (INSPECT) data base or through the patient's integrated health record before prescribing certain medications if the patient is enrolled in a hospice program.	us/states/in	Indiana General Assembly	2023	HB 1445	Indiana HB 1445 (2023)	bill	ATTORNEY GENERAL AUDITS AND AUDITORS DRUGS AND MEDICINES HEALTH Health Care Costs; Health Insurance STUDY COMMITTEES WELFARE Medicaid	enacted	Andy Zay Ann Vermilion Ed Charbonneau Mike Bohacek	6	34	1	2023-01-17	2023-05-04	openstates	ocd-bill/9a29def1-d3bd-4803-b390-bb76a89a4d19	http://iga.in.gov/legislative/2023/bills/house/1445	38b6cbf07ac97183221cd593a469fc19ad429f6585747d2800819894f476584f	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-in

Indiana HB 1445 (2023) — Audit of Medicaid program prescription drug costs.

Amends the requirements for a physician to provide office based opioid treatment. Provides that the attorney general may issue a request for proposal to audit the prescription drug programs within the state employee health plan and the Medicaid program. Provides that the attorney general may evaluate and determine whether to include specified metrics in the request for proposal. Provides that the audit look back period must be the previous five state fiscal years. Provides that the results of the audits must be provided to the interim study committee on public health, behavioral health, and human services before September 1, 2024. Provides that a practitioner is not required to obtain information about a patient from the Indiana scheduled prescription electronic collection and tracking program (INSPECT) data base or through the patient's integrated health record before prescribing certain medications if the patient is enrolled in a hospice program.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Enrolled House Bill (H) (committee substitute) — source
2. House Bill (H) (committee substitute) — source
3. House Bill (H) (committee substitute) — source
4. House Bill (S) (committee substitute) — source
5. House Bill (S) (committee substitute) — source
6. Introduced House Bill (H) (committee substitute) — source

Votes

• HB 1445 - Bohacek - 3rd Reading — 50–0 (pass) · upper

Sponsors

• Andy Zay — primary (person)
• Ann Vermilion — primary (person)
• Ed Charbonneau — primary (person)
• Mike Bohacek — primary (person)
• Gregory Porter — coauthor (person)
• Martin Carbaugh — coauthor (person)
• Matt Lehman — coauthor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2023-01-17 Coauthored by Representative Lehman
• 2023-01-17 Authored by Representative Vermilion
• 2023-01-17 First reading: referred to Committee on Public Health reading-1, referral-committee
• 2023-01-19 Representative Schaibley added as coauthor
• 2023-02-07 Committee report: amend do pass, adopted committee-passage
• 2023-02-07 Referred to the Committee on Ways and Means pursuant to House Rule 127
• 2023-02-13 Representative Schaibley removed as coauthor
• 2023-02-13 Representatives Carbaugh and Porter added as coauthors
• 2023-02-20 Committee report: amend do pass, adopted committee-passage
• 2023-02-22 Second reading: ordered engrossed reading-2
• 2023-02-23 Senate sponsors: Senators Bohacek, Charbonneau, Zay
• 2023-02-23 Third reading: passed; Roll Call 224: yeas 92, nays 0 passage, reading-3, reading-3
• 2023-02-24 Referred to the Senate referral
• 2023-03-06 First reading: referred to Committee on Insurance and Financial Institutions reading-1, referral-committee
• 2023-03-30 Committee report: do pass adopted; reassigned to Committee on Appropriations committee-passage, referral-committee
• 2023-04-13 Committee report: amend do pass, adopted committee-passage
• 2023-04-17 Second reading: ordered engrossed reading-2
• 2023-04-18 Third reading: passed; Roll Call 439: yeas 50, nays 0 passage, reading-3, reading-3
• 2023-04-18 Returned to the House with amendments receipt
• 2023-04-19 Motion to dissent filed filing
• 2023-04-19 House dissented from Senate amendments
• 2023-04-19 House conferees appointed: Vermilion and Porter
• 2023-04-19 House advisors appointed: Carbaugh, Ledbetter and Fleming
• 2023-04-20 Senate conferees appointed: Bohacek and Qaddoura
• 2023-04-20 Senate advisors appointed: Randolph Lonnie M, Charbonneau and Zay
• 2023-04-27 CCR # 1 filed in the House filing
• 2023-04-27 CCR # 1 filed in the Senate filing
• 2023-04-27 Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 553: yeas 95, nays 0
• 2023-04-28 Signed by the President of the Senate passage
• 2023-04-28 Signed by the President Pro Tempore passage
• 2023-04-28 Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 533: yeas 50, nays 0
• 2023-05-01 Signed by the Speaker passage
• 2023-05-04 Signed by the Governor executive-signature
• 2023-05-04 Public Law 233 became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/9a29def1-d3bd-4803-b390-bb76a89a4d19. Confidence: reported (aggregated from official Indiana legislature records).